These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 3552350

  • 1. Myelodysplastic syndromes: natural history and features of prognostic importance.
    Mufti GJ, Galton DA.
    Clin Haematol; 1986 Nov; 15(4):953-71. PubMed ID: 3552350
    [No Abstract] [Full Text] [Related]

  • 2. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
    Galton DA.
    Scand J Haematol Suppl; 1986 Nov; 45():11-20. PubMed ID: 3515515
    [No Abstract] [Full Text] [Related]

  • 3. Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome.
    Knipp S, Strupp C, Gattermann N, Hildebrandt B, Schapira M, Giagounidis A, Aul C, Haas R, Germing U.
    Leuk Res; 2008 Jan; 32(1):33-7. PubMed ID: 17412418
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chromosome studies in human hematologic diseases: II. Myelodysplastic syndromes.
    Larripa I, Labal de Vinuesa M, Bengiò R, Slavutsky I.
    Haematologica; 1987 Jan; 72(5):399-403. PubMed ID: 3121461
    [No Abstract] [Full Text] [Related]

  • 9. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
    Estey EH, Keating MJ, Dixon DO, Trujillo JM, McCredie KB, Freireich EJ.
    Hematol Pathol; 1987 Jan; 1(4):203-8. PubMed ID: 3504436
    [Abstract] [Full Text] [Related]

  • 10. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K.
    Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
    [Abstract] [Full Text] [Related]

  • 11. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
    Omine M, Yamauchi H.
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome.
    Suciu S, Kuse R, Weh HJ, Hossfeld DK.
    Cancer Genet Cytogenet; 1990 Jan; 44(1):15-26. PubMed ID: 2293879
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors in refractory anemias.
    Oguma S, Yoshida Y, Uchino H, Maekawa T.
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1412-8. PubMed ID: 3247816
    [No Abstract] [Full Text] [Related]

  • 16. [Myelodysplastic syndromes].
    Sainty D, Horschowski N, Fossat C, Sampol J.
    Ann Biol Clin (Paris); 1985 Dec; 43(6):821-30. PubMed ID: 3914223
    [No Abstract] [Full Text] [Related]

  • 17. Refractory anemia with ringed sideroblasts (primary acquired sideroblastic anemia).
    Tomonaga M.
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1419-27. PubMed ID: 2854694
    [No Abstract] [Full Text] [Related]

  • 18. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
    Belli C, Acevedo S, Bengio R, Arrossagaray G, Watman N, Rossi N, García J, Flores G, Goldztein S, Larripa I.
    Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
    [Abstract] [Full Text] [Related]

  • 19. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
    Müller-Berndorff H, Haas PS, Kunzmann R, Schulte-Mönting J, Lübbert M.
    Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
    [Abstract] [Full Text] [Related]

  • 20. [Clinical, hematologic and developmental characteristics of myelodysplastic syndromes. Study of a group of patients with a long-term follow-up].
    Di Giovanni S, Giallonardo P, Costa MP, Carducci P.
    Recenti Prog Med; 1987 Feb; 78(2):63-8. PubMed ID: 3473582
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.